Janssen wants you to help us ‘hatch’ a plan to improve Australia’s health

Inspiring Innovation in Australian Healthcare

“ The best way to predict the future is to invent it” Alan Kay

About the 2014 HaTCH Challenge

Janssen wants you to help us ‘hatch’ a plan to improve Australia’s health.

Created by Janssen Australia, HaTCH, is about creating a better future for healthcare in Australia. We believe in innovation; one bold idea is all it takes to make a difference. If you have a great idea incubating, and you want to change healthcare as we know it, then enter today and help us create a healthier future for Australia.

HaTCH is looking for innovation that will inspire Australians to better connect with their own health and wellbeing. We would love to see innovation that:• Improves access to and sharing of health information • Transforms healthcare from an individual endeavour into a journey more closely connected to others• Grabs people’s attention and make them want to actively manage their health and wellbeing at every stage of their life

In Australia, in line with the National Health Priorities, we need more innovation in the areas of:• Obesity • Drug and alcohol abuse • Mental health

Additionally, Janssen is interested to see how new innovations discovered in HaTCH can also intersect in therapeutic areas of diabetes, mental health, oncology, virology and immunology.

Anyone can enter the challengeHaTCH gives health entrepreneurs, start-ups and community organisations some critical investment to drive growth and innovation in Healthcare. 2014 is the inaugural year of HaTCH and we can’t wait to see what Australia’s healthpreneurs have to show us. By the end of the competition (Dec 2014), organisations will ideally have a Minimum Viable Product (MVP) and ideally be at growth stage.

As a member of Australia’s healthcare community Janssen wants to support the next generation of Australian innovation in this space.

The Prize*

• 4finaliststoeachreceive$10,000• Finalists will collaborate with industry experts to workshop their ideas and business plans • Asinglewinnerwillthenbechosentoreceive$100,000tokick-startcommercialisationoftheiridea

*Please refer to terms and conditions for full details and conditions relating to the prize

The HaTCH Brief

Peoplearelivinglongerbutthey’renotalwayslivinghealthier.Chronicdiseasenowplacesasignificantstrainonourhealthcaresystemandourcommunity.By2020wewillbefacing unprecedented demand for care for our aging population proportion of people with life limiting illness.

Local healthcare experts are suggesting that: • Australia needs more programs to manage health issues outside of hospital• If we can reduce the number of hospitalisations we will help with the rising cost of healthcare• If we improve the transitions between hospital and community based care we can reduce the burden on the system. This might happen through better monitoring in the

community, better information sharing and better connectedness to service

So this got Janssen thinking… how about we ‘hatch’ a plan to improve Australia’s health.

We are looking to inspire Australians to better connect with their healthcare.

HaTCH is seeking entries from start-ups, entrepreneurs, and organisations that have developed commercially viable new ideas to help keep Australians healthier, happier and out of hospital for as long as possible.

HaTCH aims to support the healthcare start up community with funding to develop BREAKTHROUGH innovation that is unique and relevant to the needs of the Australian healthcare system.

What is the HaTCH vision of success?

Innovationthatmakesbeinghealthierfunandexcitingagain!Specifically:• A measurable improvement in the quality of lives of a patient cohort outside of hospital• A healthier Australian community who can be supported in their homes for longer• A reduction in the average number of hospital admissions per year of patients with chronic diseases• An innovation that is commercial viable to ensure its sustainability

Suggested areas of focus• As a country the challenge is particularly relevant in the areas of obesity, drug and alcohol abuse and mental health. • As a company, Janssen is interested in how these areas intersect with diabetes, mental health, oncology, virology and immunology.

The Judging Process

At HaTCH we know that ideas don’t turn into commercial opportunities all by themselves. You need expertise, experience and strong industry connections.

RawInnovationwillfacilitatethejudgingprocesstoselectthetop4ideastoprogressthroughtofinalstageofthecompetition.

The judging panel will judge all entries based on the following criteria (including but not limited to):a. Applicability to the challengeb. Qualityoftheidentifiedneedandtargetmarketc. Scalability to meet the needs of a large population in a similar environmentd. Depth of understanding of patients and the healthcare communitye. Ability of the entrant and/or the Promoter to execute the planf. Alignment with areas of interest for Australian healthcare and the Promoter’s areas of expertiseg. Clear path to commercialisationh. The extent to which the initiative proposed is commercially sustainablei. The extent to which the initiative proposed is a disruptive and innovative approach to the solution

EachfinalistteamwillhavetheopportunitytoworkshoptheirideaswiththementorsduringthegreenhouseandmentoringdayinSydney.

Thefinalistmentoringprogramwillincludeinnovationandideationtraining,pitchcoachingandcollaborationwithsomeveryseniorhealthcareexperts,doctorsandprofessionalstoput each team in the best possible place for market success.

The HaTCH timeline:

Monday 15th September: HaTCH launch Friday 3rd October: Entry deadlineTuesday 7th October: Finalists announcedWednesday8thOctober: Finalistsawarded$10KcashprizeThursday 30th October: Greenhouse and mentoring day in SydneyTuesday 2nd December: Finalist pitch day Wednesday 3rd December: Winner announced

Your Entry

Entries should be no more than 2000 words. Please submit entry via online entry page at www.janssenhatch.com.au. Entrants can tackle this brief in whatever way they choose, but eachentryshouldbestructuredtoaddressthefivecriteria.Duetothenatureofthiscompetition,pleasecarefullyreadtheTermsandConditionspriortoentering.

What is the idea?A clear and concise articulation of your idea. Keep it simple. (100 words as a guide)

Insight?What is the evidence that your idea is needed and will make an impact on Australian healthcare? Make sure your data is accurate, well sourced and persuasive.

Top Tip: Your insight will sell your idea.(500 words as a guide)

Target Audience? Who is the target audience for your innovation and how will you connect with them? (50 words as a guide)

How does it work?How does your idea work? What is the implementation plan? (1000 words as a guide). For example:

• Outline the functionality and user journey• Who are the users? What do they do?• Howwillpeoplefindoutaboutit?• What is needed to develop your idea? Money, time, personnel, equipment etc• Anticipated timeline• Are there any partners involved, such as healthcare professionals, NGOs, etc?• What is your commercial business model?

Vision of success and measurement(350 words as a guide)

• What is your vision of success is for this idea? • How will we know when we achieve success? • When and how will you measure it?

Panel of Experts

Introducingourfiveoutstandinghealthcareandstartupexpertpanelists.

Professor Mukesh Haikerwal AO

AO, M.B.; CH.B., DIP. I.M.C.R.C.S. (ED.), D.R.C.O.G.(DIPLOMA), CERT. J.C.P.T.G.P., D.R.A.N.Z.C.O.G.

Professor Mukesh Haikerwal is a leader and passionate advocate for the use of technology in the health sector. For 6 years until 2013, Mukesh was the National Clinical Lead and Head of the Clinical Leadership & Stakeholder Management Unit at Australia’s the National e-Health Transition Authority (NEHTA). He also worked on the National Health and Hospital Reform Commission formulating a future vision for Australia’s health including using eHealth as an enabler.

Mukesh is a General Medical Practitioner in Melbourne and current chair of Council of the World Medical Association, working on the areas of Medical Ethics, Social and Medical Affairs and in capacity building and advocating for the need for health and health care as a wise investment for Nations. Also holding positions; Professor in the School of Medicine at Flinders University in Adelaide, Chair of the beyondblue National Doctors’ Mental Health Program, Co-Chair of the Australian Asian Medical Federation and a member of the Advisory Board of Brain Injury Australia.

Mukesh was awarded the Order of Australia in 2011 for distinguished service to medical administration, to the promotion of public health through leadership roles with professional organisations. These positions included being the 19th Federal President of the Australian Medical Association (AMA), its Federal Vice President and, prior to that AMA Victorian State President. This saw him responsible for national policy development, lobbying with federal parliamentarians, co-ordinating activity across the AMA State entities and representing the AMA and its members nationally and internationally.

Amit Vohra

GBQ, MBA, GAICD, AFACHSM

Amit Vohra is a senior health executive, with a demonstrated record of business success in the Australian health sector.

With a passion for grassroots-driven and outcome-focused practical solutions, Amit brings a fresh, entrepreneurial outlook to health policy. He has launched a number of innovative programs to boost supply of future GPs and is particularly interested in reducing fragmentation across the health care system.

Amit was CEO General Practice Registrar Australia, the peak representative body for junior doctors from April 2006 – July 2014 during which time he has expanded the company by over 500% making it the fastest growing medical membership organization in Australia.

Amit has particular interest in improving health workforce distribution, participation and efficiencyandhassatonanumberofcommonwealthcommitteesandprograms.Duringthis time he has provided high-level advice across a number of commonwealth programs nettingefficiencygainsofover$500million.

AmitwaslistedamongsttheTop50InfluentialPeopleinGeneralPracticein2010by Australian Doctor, and is widely recognised as a thought leader on key national health system issues. Amit has a Masters in Business and is a graduate member of the AustralianInstituteofCompanyDirectors.HeiscurrentlyfinishinghisPhDwithafocuson health workforce.

Panel of Experts

Chris Hourigan

JANSSEN MANAGING DIRECTOR AUSTRALIA / NEW ZEALAND

Chris was appointed to the position of Managing Director for Janssen Australia & New Zealand on 1 October 2012, returning to Australia after completing several overseas postings, the most recent as Managing Director for Janssen Vietnam. Prior to that, Chris was Business Unit Director for the Janssen New Zealand business and he spent several years in the USA as Global Marketing Leader for the Psychiatry portfolio.

Chris is member of the Medicines Australia Board and brings a wealth of experience in the healthcare industry to the judging panel.

Chris’s vision for the pharmaceutical industry in Australia is to ensure the ANZ public receives access to innovative medicines and also to continue the globally recognised level of excellence in ANZ’s clinical research activities, which are continually looking for cures and better methods of disease management.

Cyrus Allen

PARTNER, STRATIVITY GROUP AUSTRALIA & NEW ZEALAND

Cyrus is a senior customer executive with deep consulting and operational experience across customer strategy, customer experience management, digital, marketing and service design. As a Partner with Strativity Group, Cyrus builds on 20 years of local and international experience in senior product, Brand and customer experience roles with Ericsson, Sony Ericsson, Telstra and most recently ANZ Banking Corporation.

Cyrus works with organisations to improve the experiences they deliver through definingandimplementingcustomerexperiencestrategies.HisworkincludesOmni-channel design, experience innovation, customer strategy assessment, Branded experience design and VOC program development. He holds a Master’s Degree in Marketing, Bachelor’s Degrees in Business and Arts, and has completed a custom executive program at AGSM. Cyrus is an adviser to two technology start-ups and serves as a Board Director for Gowrie Victoria, a leader in early childhood education.

Panel of Experts

Mick Liubinskas

HEAD COACH AT MURU-D ACCELERATOR, POLLENIZER CO-FOUNDER, OOMPH DIRECTOR, WOOBOARD CHAIRMAN

Mick Liubinskas is a high energy, technology entrepreneur, advisor, investor and industry leader.

He programmed his Commodore 64 at age 12, sold computer networks at age 17, raised capital for a business at 22 and ran marketing globally for Kazaa at 26.

For the past 8 years he has co-founded and worked with more than 30 technology startup companies, including starting Pollenizer with Phil Morle. This has included evaluating ideas, buildingfirstproducts,launchingintheUSA,raisingangelandventurecapital,sellingabusinessand all the emotional rollercoaster rides in between.

His most successful companies are Oomph which is leading the world in iPad publishing and SpreetswhichsoldtoSpreetsfor~$40min13months.

Mick is often known as Mr Focus due to his strong drive for starting small and fast, embracing failure on the road to success and avoiding the entrepreneurial distractions.

He’s also proud of his role in helping to establish and build the technology entrepreneur industry in Sydney and Australia, including accidentally founding Silicon Beach Drinks. Master’s Degree in Marketing, Bachelor’s Degrees in Business and Arts, and has completed a custom executive program at AGSM. Cyrus is an adviser to two technology start-ups and serves as a Board Director for Gowrie Victoria, a leader in early childhood education.

About the Sponsor

Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes).

WehaveaproudheritageinourfounderDrPaulJanssenwhoestablishedthecompanywithastronggroundinginscienceandinnovativesolutions,alwaysputtingpatientsfirst.Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. More information can be found at www.janssen.com.au

SUBMIT YOUR ENTRY AT JANSSENHATCH.COM.AU TODAY!Before you submit, please read the terms and conditions and the privacy policy very carefully to ensure you understand and comply with the terms and conditions of entering the challenge. Both policies can be found at www.janssenhatch.com.au . If your entry is seen to void the terms and conditions we will be unable to consider you for a prize.

HaTCH – Terms and Conditions

1 Informationregardingcashawardsandhowtoenterformspartoftheseconditions.Byentering,entrantsaccepttheseconditions.Nothingintheseconditionsrestricts,excludesormodifiesorpurportstorestrict,exclude or modify any statutory consumer rights under any applicable law including the Competition and Consumer Act 2010 (Cth).

2 Entry is open only to Australian residents aged 18 years or older or Australian companies having greater than 51% Australian ownership and that have at least one Board Member who is an Australian resident. Individual entrants may participate with other entrants as teams, in which case each entrant agrees to be bound by these terms and conditions. Directors, management and employees of the Janssen-Cilag Pty Ltd (Promoter) and associated companies and agencies involved with the competition as well as the immediate families of each of these people are not eligible to enter.

Phase 1

3 Phase 1 of the competition begins at 9:00 AM on Monday 15th September 2014 and closes at 6:00PM on Friday 3rd October 2014 (Phase 1 Competition Period).

To enter Phase 1 of the competition, entrants must, during the Phase 1 Competition Period submit an Eligible Proposal (see clause 4 below) via the HaTCH website at www.janssenhatch.com.au together with their personal contact details.

4 An Eligible Proposal is a submission that:

(a) is submitted via the online “Submit An Entry” web form located at www.janssenhatch/submit-an-entry of 2000 words or less (appendices are not included in this word count);

(b) addresses the following questions: What is the idea? What is the insight? Who is the target audience? How does it work? What is the vision of success and measurement? ;

(c) provides innovation in the area of disease prevention and wellness outside of hospital; and addresses the challenge outlined on the Brief page of the website www.janssenhatch.com.au/the-brief being commerciallyviablenewideas-withspecificinterestininnovativesolutionsintheareasofearlydetectionandmonitoring;betterconnection;andinformationsharing-tohelpkeepAustralianshealthier,happier, and out of hospital for as long as possible.

5 Phase 1 entries must be received by the Promoter during the Phase 1 Competition Period. Each entrant may only enter Phase 1 once.

6 The Promoter’s judging panel (Judging Panel) will review all valid entries received during the Phase 1 Promotion Period. On 7th October 2014, the judging panel will judge all entries based on the following criteria (including but not limited to):

(a) applicability to the challenge

(b) qualityoftheidentifiedneedandtargetmarket

(c) scalability to meet the needs of a large population in a similar environment

(d) depth of understanding of patients and the healthcare community

(e) ability of the entrant and/or the Promoter to execute the plan

(f) alignment with areas of interest for Australian healthcare and the Promoter’s areas of expertise

(g) clear path to commercialisation

(h) the extent to which the initiative proposed is commercially sustainable

(i) the extent to which the initiative proposed is a disruptive and innovative approach to the solution

7 The four entries judged to be the best Phase 1 entries will each:

(a) be shortlisted as “Phase 1 Finalists” and will proceed to Phase 2 of the competition; and

(b) receivetheopportunitytofurtherdeveloptheirEligibleProposalwiththePromoter(includingreceivingafundinggrantofAUD$10,000intheformofanelectronicfundstransfertothePhase1Finalist’snominated bank account) (Phase 1 Award).

8 In consideration for receiving the award set out in clause 7, each Phase 1 Finalist agrees that during Phase 2 of the promotion, it will not:

(a) during the Phase 2 Competition Period, offer or grant any rights in, or in relation to, all or part of its Eligible Proposal, including any right to develop or commercialise any part of its Eligible Proposal;

(b) during the Phase 2 Competition Period, work with, or offer to work with, any person other than the Promoter, in relation to its Eligible Proposal; and

(c) after the Phase 2 Competition Period for a period of 12 months, offer or grant any rights in, or in relation to, all or part of its Eligible Proposal, including any right to develop or commercialise any part of its Eligible Proposal,unlessithasfirstofferedthoserightstothePromoteronthesame(ormorefavourableterms),andthePromoterhasnot,within60days,acceptedthePhase1Finalist’soffer.

9 ThePhase1FinalistswillbenotifiedbyWednesday8thOctober2014byphoneandemail.ThefundinggrantwillbetransferredtothePhase1FinalistsbyelectronicfundstransferonFriday10thOctober2014.

Phase 2

10 Phase 2 of the competition begins at 9:00AM on Thursday 9th October 2014 and closes at 6:00PM on Tuesday 2nd December 2014 (Phase 2 Competition Period).

11 To enter Phase 2 of the competition, Phase 1 Finalists must

(a) bynolaterthan6:00pm,Friday28thNovember2014,submitviahatch@janssen.com.auawrittenfinalproposalbeingafurtherdevelopmentofthePhase1Finalist’sEligibleProposal,thatisnolongerthan20A4pages at size 11 Arial font (excluding appendices);

(b) on Tuesday 2nd December 2014 (Pitch Day), present a 30 minute presentation to the Judging Panel in front of an audience (selected at the discretion of the Promoter), and respond to questions in an additional question session from the Judging Panel.

12 Each Phase 1 Finalist may only enter Phase 2 once. Phase 1 Finalists are entitled to attend a workshop day on Thursday 30th October 2014 (Workshop Day) with experts, and Promoter personnel, who are selected by the Promoter.

13 The Promoter’s judging panel will review all valid entries received during the Phase 2 Competition Period. On December 3rd 2014 the judging panel will judge all entries based on the criteria set out in clause 6

14 The entry judged to be the best entry will receive the opportunity to collaborate with the Promoter to further develop their Final Proposal to a “minimal viable product” (MVP) , subject to the “Phase 2 Winner” entering into a Collaboration Agreement with the Promoter, under which the Promoter will, subject to the terms of that Collaboration Agreement (which will be in the form provided by the Promoter and negotiated andagreedbetweenthePromoterandthePhase2Winner),provideseedfundingofAUD$100,000(Phase2Award).

15 Only ONE winner will be selected as the Phase 2 Winner.

16 ThePhase2WinnerwillbenotifiedinpersonatanawardceremonyonDecember3rd2014.

17 Transport to and from the Workshop Day, Pitch Day and awards ceremony, and accommodation is not included in the Phase 1 Award. Phase 1 Finalists are required to arrange their own transport and accommodation inrelationtotheseevents.TheseeventswillbeheldinSydney,Australiawithfurthervenuedetailstobeconfirmedclosertotherelevantdates.

Other conditions

18 ThetotalawardpoolisvaluedatAUD$140,000.

19 This competition is judged on skill and chance plays no part in determining the winners.

20 The Judging Panel reserves the right not to review appendices to entries. Entrants should ensure that all critical details are included in the main sections of their entries.

21 The Promoter accepts no responsibility for any late, lost, incomplete, incorrectly submitted, delayed, illegible, corrupted or misdirected entries, votes or correspondence, whether due to error, omission, alteration, tampering, deletion, theft, destruction, transmission interruption, communications failure or otherwise.

22 ThePromoterhasnocontrolovermobiletelephonecommunications,networksorlinesandacceptsnoresponsibilityforanyproblemsassociatedwiththem,whetherduetotrafficcongestion,technicalmalfunctionor otherwise.

23 The Promoter is not liable for any consequences of user error including (without limitation) costs incurred.

24 Each entrant is responsible for the entry they submit and responsible for paying any costs associated with entering the competition.

25 Eligible Proposals and Final Proposals must be in English

26 Entries that are found to have been derived from third party work will be considered invalid and, if that entry is successful, any award must be returned to the Promoter. Without limiting the generality of other conditions, the Promoter reserves the right to take legal action against anyone found to have breached this condition. The Promoter reserves the right in its sole discretion to (i) not consider any entry which is not in accordance with these conditions of entry; and (ii) to disqualify any individual who the Promoter has reason to believe has breached any of these conditions of entry or engaged in any unlawful or other improper misconduct calculated to jeopardise the fair and proper conduct of the competition. The Promoter’s legal rights to recover damages and other compensation are reserved.

27 Each entrant warrants and agrees that:

(a) the entrant has created the entry themself, or if in a team, the entrant has created the entry only in conjunction with the other team entrants;

(b) the entrant is entitled to reproduce and exploit all of the underlying works in the entry;

(c) the entrant will not submit material in their entry that is copyrighted, protected by trade secret or otherwise subject to third party proprietary rights, including privacy and publicity rights, unless the entrant is the owner of such rights;

(d) the entry has not been previously published in any other medium or forum worldwide;

(e) the entrant will not submit material that is unlawful, obscene, defamatory, derogatory, threatening, pornographic, sexually inappropriate, violent, abusive, harassing, hateful, racially, religiously or ethnically offensive, or encourages, evidences or indicates conduct that would be considered a criminal offence, gives rise to civil liability, or violates any law;

(f) the entry will not contain viruses or cause injury or harm to any person or entity; and

(g) the entrant has not granted rights to their entry to any other person which is inconsistent with the rights granted to the Promoter.

28 EachentrantacknowledgesthatnothinginthispromotionaffectstherightsofthePromoteroritscorporateaffiliatesfromdevelopingandusingideasindependentlyofthosesubmittedinentries.

29 As a condition of accepting the Phase 1 Award, and without limiting clause 8, entrants agree to sign (if required by the Promoter) a statutory declaration regarding the originality of their entry.

30 As a condition of accepting the Phase 2 Award, and without limiting clause 14, entrants agree to sign (if required by the Promoter) a statutory declaration regarding the originality of their entry.

31 Each entrant acknowledges and agrees that if their entry wins an award, the Promoter (and each of its assignees and licensees) has the right, in its absolute discretion, to edit, amend, copy, use, publish, broadcast and communicate to the public, the entry in any media including television and the internet, without any further consultation, reference, payment or any other compensation to the entrant.

32 Each award winner must, at the Promoter’s request, participate in all promotional activity (such as publicity and photography) surrounding the winning of the award, free of charge, and they consent to the Promoter using their name and image in promotional material in any medium throughout the world.

33 Each entrant must create their own entry and only submit an entry in their own name.

34 Once any award has left the Promoter’s/supplier’s premises, the Promoter and its agencies and companies associated with the competition will not be responsible for any delay in delivery, loss or damage to the award.

35 ThePromotermayrequireawinnertoverifytheirentryandprovideproofofidentity,proofofageandproofofresidencyatthenominatedawarddeliveryaddress.ProofconsideredsuitableforverificationisatthePromoter’s discretion.

36 ForentrantswhoareaffiliatedwiththePromoter’scustomersorgovernmentagencies/institutions,additionaldiligencemayberequiredpriortoenteringPhase2orexecutingtheCollaborationAgreement.

37 Ifawinningentryisdeemednottocomplywiththeseconditionsofentry,theentrywillbediscardedandanalternatewinnerwillbeselected.Thejudges’decisionisfinalandnocorrespondencewillbeenteredinto.

38 The Promoter may verify the validity of entries, and in its sole discretion, disqualify all entries from, and prohibit further participation in this competition by, any person or team who manipulates or tampers with or benefitsfromanymanipulationofortamperingwiththeentryprocessortheoperationofthecompetition(including,butnotlimitedtosolicitingvotes,disguisinganIPaddress,usingmultipleemailaddressesoraliases to submit multiple entries for the same person, or other electronic account) or acts in violation of these conditions, acts in a dishonest or disruptive manner, acts with the intent to annoy, abuse, threaten or harassanyotherperson,oractsinawaytojeopardisethefairoperationofthecompetition..ThePromoter’sdecisioninrelationtoallaspectsofthecompetitionisfinalandnocorrespondencewillbeenteredinto.

39 Awards are not transferable or exchangeable. In the event for any reason a winner does not take an element of the award at the time stipulated by the Promoter then that element of the award will be forfeited by the winner. Where an award is unavailable for any reason, the Promoter may substitute another item of equal or higher value as determined by the Promoter.

40 Intheeventofanawardnotbeingacceptedorclaimed,orrefusalbythewinnertoexecuteaCollaborationAgreement,orduetoanotifiedconflictofinterest,thejudgesmayelecttoselectanalternatewinnerwiththe entry judged to be the next best entry to receive that award.

41 ThePromoterreservestherightnottoawardtheAU$100,000ifthejudgingpaneldonotdeemanyentrytobeawinner

42 If for any reason any aspect of this competition is not capable of running as planned, including by reason of infection by computer virus, mobile network failure, bugs, tampering, manipulation, unauthorised intervention, fraud, technical failures or any cause beyond the control of the Promoter which corrupts or affects the administration, security, fairness, integrity or proper conduct of this competition, the Promoter may in its sole discretion cancel, terminate, modify or suspend the competition, or invalidate any affected entries.

43 ThePromoteranditsassociatedagenciesandcompanieswillnotbeliableforanyloss(including,withoutlimitation,indirect,specialorconsequentiallossorlossofprofits),expense,damage,personalinjuryordeathwhich is suffered or sustained (whether or not arising from any person’s negligence) in connection with this competition or accepting or using any award, except for any liability which cannot be excluded by law (in which case that liability is limited to the minimum allowable by law).

44 ThePromoteracceptsnoresponsibilityforanytaximplicationsthatmayarisefromtheawardwinnings.Independentfinancialadviceshouldbesought.

45 All times referred to in these terms and conditions are Australian Eastern Standard Time

46 The Promoter is Janssen-Cilag Pty Ltd, ABN: 47000129975, 66 Waterloo Road, Macquarie Park, NSW 2118 Australia.